News

Drugs of Choice for Barrett’s Esophagus
Jeannette Y. Wick, RPh, MBA, FASCP
Barrett’s esophagus (BE) is a serious gastrointestinal condition in which acid reflux predisposes the esophagus to increased cell proliferation and decreased apoptosis.
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued a statement in response to a new report released by the AARP Public Policy Institute.
Krystle Vermes
ZS Pharma is requesting FDA approval for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
Advancing roles for pharmacists providing diabetes care requires application of knowledge and skills, problem solving, and working on interprofessional teams.
Ryan Marotta, Assistant Editor
Patients remain largely uninformed about the dangers of unnecessary disease screening and overdiagnosis.
Meghan Ross, Associate Editor
The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.
Allison Gilchrist, Associate Editor
West Virginia’s highest appellate court recently ruled prescription drug abusers can sue pharmacists for enabling their addictions.
Krystle Vermes
Amgen has terminated its co-development and commercialization of brodalumab with AstraZeneca after observing suicidal ideation and behavior in clinical trial participants.

Association News

National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued a statement in response to a new report released by the AARP Public Policy Institute.
Advancing roles for pharmacists providing diabetes care requires application of knowledge and skills, problem solving, and working on interprofessional teams.
NABP
The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.
However, AMCP is disappointed that the bill stripped an earlier provision that would have addressed payment fraud in the Medicare Part D prescription drug benefit program.
The APhA designed the Patient Self-Management Credential for Diabetes to create meaningful interactions between patients and providers.

Pharmacy Market News

PRNewswire
Johnson & Johnson (NYSE: JNJ) today announced the acceptance of the March 1, 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion.
Pfizer Inc. today announced the launch of a competitive, peer-reviewed grants program to support clinical research projects investigating IBRANCE® (palbociclib) in advanced breast cancer.
BUSINESS WIRE
Merck and NanoString Technologies, Inc. today announced a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures.

Strategic Alliance Partner News

PRNewswire
Later this week, Cardinal Health Specialty Solutions will present a new series of health economic outcomes research (HEOR) studies.
$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$